Envisioning a Transformed Clinical Trials Enterprise in the United States : Establishing an Agenda for 2020
Work detail
This page groups all known editions belonging to the same underlying work.
Overview
Shared work-level identity and catalog context.
Contributors
People credited with this work in the active catalog.
- Open Author
Neil Weisfeld
- Open Author
Institute of Medicine
- Open Author
Board on Health Sciences Policy
- Open Author
Rebecca A. English
- Open Author
Forum on Drug Discovery, Development, and Translation
- Open Author
Anne B. Claiborne
Editions
Publication-specific versions linked to this work only.
- Image source: Open LibraryEA
Envisioning a Transformed Clinical Trials Enterprise in the United States : Establishing an Agenda for 2020
- EAEnvisioning a Transformed Clini...Neil Weisfeld, Rebecca A. English, Anne B. Claiborne, Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy
Envisioning a Transformed Clinical Trials Enterprise in the United States : Establishing an Agenda for 2020
- EAEnvisioning a Transformed Clini...Institute of Medicine, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Anne B. Claiborne, Rebecca A. English
Envisioning a Transformed Clinical Trials Enterprise in the United States : Establishing an Agenda for 2020
- EAEnvisioning a Transformed Clini...Institute of Medicine, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Anne B. Claiborne, Rebecca A. English
Envisioning a Transformed Clinical Trials Enterprise in the United States : Establishing an Agenda for 2020